2014 缺血性卒中/短暂性脑缺血发作患者合并心房颤动的筛查及抗栓治疗中国专家共识

2014-08-01 中华预防医学会 中华内科杂志.2014,53(8):665-671.

目前,我国对缺血性卒中/短暂性脑缺血发作(TIA)患者合并AF存在诊断率偏低现象,尤其是对阵发性AF另一方面,近年有关AF抗凝治疗的研究进展迅速,尤其是新型口服抗凝剂(NOACs)预防AF患者卒中和系统性栓塞取得了突破性进展,相关的指南和专家共识也已发布为此,国家卫生和计划生育委员会脑卒中医疗质量控制中心联合中华预防医学会卒中预防与控制专业委员会组织国内部分脑血管病专家制定本共识,着重讨论缺血性卒

中文标题:

2014 缺血性卒中/短暂性脑缺血发作患者合并心房颤动的筛查及抗栓治疗中国专家共识

发布机构:

中华预防医学会

发布日期:

2014-08-01

简要介绍:

目前,我国对缺血性卒中/短暂性脑缺血发作(TIA)患者合并AF存在诊断率偏低现象,尤其是对阵发性AF另一方面,近年有关AF抗凝治疗的研究进展迅速,尤其是新型口服抗凝剂(NOACs)预防AF患者卒中和系统性栓塞取得了突破性进展,相关的指南和专家共识也已发布为此,国家卫生和计划生育委员会脑卒中医疗质量控制中心联合中华预防医学会卒中预防与控制专业委员会组织国内部分脑血管病专家制定本共识,着重讨论缺血性卒中/TIA患者合并AF的筛查和二级预防策(推荐意见的推荐强度及证据评定标准见文献),而对该类患者急性期治疗则请参照《中国急性缺血性脑卒中诊治指南2010》和《重组组织型纤溶酶原激活剂静脉溶栓治疗缺血性卒中中国专家共识(2012版)》。附:图1 缺血性卒中/短暂性脑缺血发作(TIA)合并心房颤动(AF)筛查流程图注:NIHSS:美国国立卫生院卒中量表;MR:磁共振;CTA:CT血管造影;MRA:磁共振血管造影;TCD:经颅多普勒;STAF:针对缺血性卒中患者的AF筛查评分;Holter:动态心电图;流程图中超声心动图对筛查AF没有直接帮助,但可帮助检出左心耳有无附壁血栓,发现其他心源性卒中证据

相关资料下载:
[AttachmentFileName(sort=100, fileName=2014 缺血性卒中/短暂性脑缺血发作患者合并心房颤动的筛查及抗栓治疗中国专家共识)] GetToolGuiderByIdResponse(projectId=1, id=66bd61c0010952e7, title=2014 缺血性卒中/短暂性脑缺血发作患者合并心房颤动的筛查及抗栓治疗中国专家共识, enTitle=, guiderFrom=中华内科杂志.2014,53(8):665-671., authorId=null, author=, summary=目前,我国对缺血性卒中/短暂性脑缺血发作(TIA)患者合并AF存在诊断率偏低现象,尤其是对阵发性AF另一方面,近年有关AF抗凝治疗的研究进展迅速,尤其是新型口服抗凝剂(NOACs)预防AF患者卒中和系统性栓塞取得了突破性进展,相关的指南和专家共识也已发布为此,国家卫生和计划生育委员会脑卒中医疗质量控制中心联合中华预防医学会卒中预防与控制专业委员会组织国内部分脑血管病专家制定本共识,着重讨论缺血性卒, cover=, journalId=null, articlesId=null, associationId=174, associationName=中华预防医学会, associationIntro=中华预防医学会是全国公共卫生预防医学领域的科技工作者自愿组成并依法在民政部登记注册的非营利性、公益性、学术性法人社团,是全国性学术团体,是发展我国预防医学科学技术和预防医学事业的重要社会力量。, copyright=0, guiderPublishedTime=Fri Aug 01 08:00:00 CST 2014, originalUrl=http://guide.medlive.cn/guideline/6693, linkOutUrl=, content=目前,我国对缺血性卒中/短暂性脑缺血发作(TIA)患者合并AF存在诊断率偏低现象,尤其是对阵发性AF另一方面,近年有关AF抗凝治疗的研究进展迅速,尤其是新型口服抗凝剂(NOACs)预防AF患者卒中和系统性栓塞取得了突破性进展,相关的指南和专家共识也已发布为此,国家卫生和计划生育委员会脑卒中医疗质量控制中心联合中华预防医学会卒中预防与控制专业委员会组织国内部分脑血管病专家制定本共识,着重讨论缺血性卒中/TIA患者合并AF的筛查和二级预防策(推荐意见的推荐强度及证据评定标准见文献),而对该类患者急性期治疗则请参照《中国急性缺血性脑卒中诊治指南2010》和《重组组织型纤溶酶原激活剂静脉溶栓治疗缺血性卒中中国专家共识(2012版)》。附:图1 缺血性卒中/短暂性脑缺血发作(TIA)合并心房颤动(AF)筛查流程图注:NIHSS:美国国立卫生院卒中量表;MR:磁共振;CTA:CT血管造影;MRA:磁共振血管造影;TCD:经颅多普勒;STAF:针对缺血性卒中患者的AF筛查评分;Holter:动态心电图;流程图中超声心动图对筛查AF没有直接帮助,但可帮助检出左心耳有无附壁血栓,发现其他心源性卒中证据, tagList=[TagDto(tagId=364, tagName=房颤), TagDto(tagId=365, tagName=卒中), TagDto(tagId=709, tagName=脑缺血)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=25, categoryName=神经外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4924, appHits=282, showAppHits=0, pcHits=3163, showPcHits=2299, likes=196, shares=13, comments=3, approvalStatus=1, publishedTime=Fri Aug 01 00:00:00 CST 2014, publishedTimeString=2014-08-01, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=fbzhang, createdTime=Fri Aug 01 00:00:00 CST 2014, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:29:51 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2014 缺血性卒中/短暂性脑缺血发作患者合并心房颤动的筛查及抗栓治疗中国专家共识)])
2014 缺血性卒中/短暂性脑缺血发作患者合并心房颤动的筛查及抗栓治疗中国专家共识
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2094946, encodeId=e89f209494679, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96035109052, createdName=1460e9dbm00暂无昵称, createdTime=Thu Oct 20 13:38:51 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057551, encodeId=18d5105e5518f, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:22:06 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954689, encodeId=d809954689e4, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:39:09 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2022-10-20 1460e9dbm00暂无昵称

    很好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2094946, encodeId=e89f209494679, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96035109052, createdName=1460e9dbm00暂无昵称, createdTime=Thu Oct 20 13:38:51 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057551, encodeId=18d5105e5518f, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:22:06 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954689, encodeId=d809954689e4, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:39:09 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-10-04 H8888888

    不错 谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2094946, encodeId=e89f209494679, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96035109052, createdName=1460e9dbm00暂无昵称, createdTime=Thu Oct 20 13:38:51 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057551, encodeId=18d5105e5518f, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:22:06 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954689, encodeId=d809954689e4, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:39:09 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    资料好好,但无法分享,遗憾!

    0